ZIOP
Ziopharm Oncology, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Market Cap: 624 Million
Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)
Shares Outstanding: 214 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.2747810296183089
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 2753 trading days
From: 2015-11-10 To: 2020-11-27
Lowest Point:
Ziopharm up 3% on FDA sign-off on study involving Sleeping Beauty platform
via: SeekingAlpha at 2019-06-11 08:06:22:000
Ziopharm Oncology ( ZIOP +3.3% ) perks up on average volume in reaction to its announcement that the FDA has signed off on a National Cancer Institute-sponsored study evaluating T-cell receptor (TCR)T-cell therapy using the company's Sleeping Beauty platform for the treatment of … read more...
Ziopharm up 3% on FDA sign-off on study involving Sleeping Beauty platform
via: SeekingAlpha at 2019-06-11 08:06:22:000
Ziopharm Oncology ( ZIOP +3.3% ) perks up on average volume in reaction to its announcement that the FDA has signed off on a National Cancer Institute-sponsored study evaluating T-cell receptor (TCR)T-cell therapy using the company's Sleeping Beauty platform for the treatment of … read more...
Ziopharm up 3% on FDA sign-off on study involving Sleeping Beauty platform
via: SeekingAlpha at 2019-06-11 08:06:22:000
Ziopharm Oncology ( ZIOP +3.3% ) perks up on average volume in reaction to its announcement that the FDA has signed off on a National Cancer Institute-sponsored study evaluating T-cell receptor (TCR)T-cell therapy using the company's Sleeping Beauty platform for the treatment of … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|